The re-import of sulphonamides to France has seen a significant decline over the years, with the volume dropping from 2.09 Thousand Kilograms in 2018 to 0.30881 Thousand Kilograms in 2022. This marks an overall decrease, emphasizing a consistent downward trajectory. Year-on-year, the re-imports have fallen by approximately 20% to 58% annually, with a compounded annual growth rate (CAGR) over the past five years indicating a sharp decline in import volumes. As of 2023, the re-import volumes have further decreased, highlighting ongoing trends.
Looking ahead, key trends to watch for include:
- Potential shifts in demand for sulphonamides due to regulatory changes and advances in pharmaceutical alternatives.
- Changes in global trade policies affecting France's import strategies and supply chain efficiencies for pharmaceutical products.
- Technological advancements and innovation in the pharmaceutical industry that might influence the supply and demand dynamics of sulphonamides.
